Amazon’s cloud business comes under U.S. antitrust scrutiny
By Akshay Kedari  Date: 2019-12-05

Amazon’s cloud business comes under U.S. antitrust scrutiny

U.S. Federal Trade Commission (FTC) has recently expanded its investigation on Amazon beyond the retail operations to the company’s cloud computing business. Lately, the U.S. antitrust enforcers was seen interviewing software firms about Amazon Web Services’ practices.

Several tech companies like Alphabet Inc.’s Google, Facebook Inc., Amazon and Apple Inc. have already faced antitrust probes issued by the state attorneys general, Congress and the federal government. Reportedly, FTC’s Technology Enforcement Division started directing its investigation of multi-sided platforms on illegal mergers and conducts after winning the antitrust approvals. However, Amazon and FTC did not comment on this development.

For the uninitiated, Amazon is the one of the largest providers of cloud services. Its major competitors include Microsoft Corp. However, smaller firms are turning out to become fierce competitors to the firm by offering cloud-based services to corporate customers and developers.

Indeed, cloud computing marks as one of the fastest-growing sectors in the IT industry. Businesses prefer to rent out servers from Amazon instead of building data centers from the ground up. Analysts predict that Amazon’s cloud unit’s sale could gross up to $34.9 billion in 2019.

Prior to this, Amazon had made headlines when it announced filing a suit with the U.S. Court of Federal Claims against the lost contract to supply cloud services to Department of Defense (DoD).

For the record, the contract, dubbed JEDI (Joint Enterprise Defense Infrastructure), included offering cloud storage of sensitive data and technology of the military to the DoD, and could result in revenue of around $10 billion over the period of 10 years.

Amazon claims that the decision was politically motivated by President Donald Trump, as he dislikes Amazon’s CEO Jeff Bezos who also owns the Washington Post. Meanwhile, Andy Jassy, CEO of AWS, shared his thoughts in an interview stating that the decision wasn’t arbitrated fairly.
 

Source Credit: https://in.reuters.com/article/uk-amazon-com-cloud-ftc/amazon-faces-u-s-antitrust-scrutiny-on-cloud-business-bloomberg-idINKBN1Y9037

About Author

Akshay Kedari    

Akshay Kedari

A qualified computer engineering graduate, Akshay Kedari takes pride in having his way with words. Following his passion for content creation, he writes insightful pieces on aeresearch.net and a few other portals. Also endorsed with a short-term experience in web deve...

Read More

More News By Akshay Kedari

Fibonacci Brands acquires Darwin from Harvest Health & Recreation
Fibonacci Brands acquires Darwin from Harvest Health & Recreation
By Akshay Kedari

Fibonacci Brands has recently announced the acquisition of Darwin from Harvest Health & Recreation (HARV.CN) as its foundation brand. Fibonacci is a leading player in the international cannabis industry. According to James George, founder of Fib...

GVN adds EVIT Center and Chumakov as its new Centers of Excellence
GVN adds EVIT Center and Chumakov as its new Centers of Excellence
By Akshay Kedari

The Global Virus Network (GVN), an international coalition of medical virologists, has recently announced the addition of Australian and Russian researchers. GVN is adding the Center for EVIT (Emerging Viruses, Inflammation & Therapeutics) of th...

Wind Point Partners takes over RTIC to expand business portfolio
Wind Point Partners takes over RTIC to expand business portfolio
By Akshay Kedari

American private equity firm, Wind Point Partners has recently signed an acquisition deal with the one of the biggest direct-to-consumer (D2C) eCommerce providers of drinkware, RTIC. Reportedly, RTIC is Wind Point’s third acquisition of a famil...

Novartis reveals positive data from Phase III ORION trials of inclisiran
Novartis reveals positive data from Phase III ORION trials of inclisiran
By Akshay Kedari

Swiss multinational pharmaceutical firm, Novartis has recently announced results from its Phase III ORION-10 and -11 studies that focus on assessing the individual responses of patients on lowering low-density lipoprotein cholesterol (LDL-C) with inc...

Medtronic to acquire Companion Medical to expand diabetes business
Medtronic to acquire Companion Medical to expand diabetes business
By Akshay Kedari

Medtronic plc, the global leader in medical technologies, has reportedly announced that it is planning to acquire insulin pen manufacturer Companion Medical. The acquisition gives Medtronic access to Companion Medical’s ‘InPen’, wh...